Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Authors: Susan Dutton, David Ferry, Jane Blazeby, Haider Abbas, Åsa Dahle-Smith, Wasat Mansoor, Joyce Thompson, Mark Harrison, Anirban Chatterjee, Stephen Falk, Angel Garcia-Alonso, D. Fyfe, Richard Hubner, Tina Gamble, Lynnda Peachey, Mina Davoudianfar, Sarah Pearson, Patrick Julier, Janusz Jankowski, Rachel Kerr, Russell Petty - The Lancet 2014 cited by 330